5 mg
Trade Name
Forsdapa
Film-coated tablet
Request Type
New Registration
Drug Type
Generic(Multisource) Drug
Approval Date
SFDA Approved Use
Type 2 diabetes mellitus
Dapagliflozin is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
- as monotherapy when metformin is considered inappropriate due to intolerance.
- in addition to other medicinal products for the treatment of type 2 diabetes.
Heart failure
Dapagliflozin is indicated in adults for the treatment of symptomatic chronic heart failure.
Chronic kidney disease
Dapagliflozin is indicated in adults for the treatment of chronic kidney disease.
Dapagliflozin is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
- as monotherapy when metformin is considered inappropriate due to intolerance.
- in addition to other medicinal products for the treatment of type 2 diabetes.
Heart failure
Dapagliflozin is indicated in adults for the treatment of symptomatic chronic heart failure.
Chronic kidney disease
Dapagliflozin is indicated in adults for the treatment of chronic kidney disease.